The approval of Vortioxetine CAS# 508233-74-7 came as exciting news at the close of September 2013. Known as the brand name Brintellix, Vortioxetine is marketed by Lundbeck and Takeda Pharmaceuticals. The FDA approval of this antidepressant is encouraging for both patients suffering from Major Depressive Disorder and the practitioners who treat these patients, as Vortioxetine[…]
FDA Approves Unique Multimodal Vortioxetine for Major Depressive Disorder
Antidepressant, FDA Approved 2013 Tags: Major Depressive DisorderserotoninSSRI Oct 07, 2013
Escitalopram Prevents Mental Stress-Induced Myocardial Ischemia in Patients with Coronary Artery Disease
Antidepressant, Drug Research & Development API Tags: AntidepressantSSRI Jun 10, 2013
On May 29, 2013 the researchers from Duke Medicine revealed new findings about the benefits of the antidepressant Escitalopram CAS# 128196-01-0. Known as the brand name Lexapro, Escitalopram has long been touted as an efficacious and safe treatment for clinical depression. The latest findings regarding Escitalopram, reported in The Journal of the American Medical Association,[…]
Vilazodone is an SSRI that Does Not Affect Sexual Function
Antidepressant, Drug Research & Development API, FDA Approved 2011 Tags: Major Depressive DisorderserotoninSSRI Nov 27, 2012
Vilazodone is in a class of medications called selective serotonin reuptake inhibitors, or SSRIs, and is also a 5HT1A receptor partial agonist. Known as the brand name Viibryd, this medication was approved in January of 2011 to treat Major Depressive Disorder in adults. In safety studies involving 2,177 patients the most common adverse side effects[…]
An Overview of Why Paroxetine Hydrochloride is Effective and Useful
Antidepressant, Bulk Active Ingredient, Drug Research & Development API, Patent Expiration 2015, TEVA API Tags: AntidepressantserotoninSSRI Aug 30, 2012
Paroxetine Hydrochloride, known by the trade name Paxil, has an upcoming patent expiration date of May 19, 2015. As a well used medication to treat depression, Paroxetine HCl, CAS number 78246-49-8, is projected to become a generic powerhouse. Paroxetine is efficacious at treating not only major depression, but also obsessive compulsive disorder, panic disorder, social[…]
Vilazodone Gets FDA Approval For Major Depressive Disorder (MDD)
Antidepressant, Drug Research & Development API, FDA Approved 2011 Tags: Major Depressive DisorderserotoninSSRI May 02, 2011
Vilazodone just received FDA approval for the treatment of major depressive depression (MDD) on January of this year. The drug will be available in 10 mg, 20 mg and 40 mg dosage forms. Major Depressive Disorder is commonly known as major depression. Unlike bipolar disorder, it is characterized by one extreme mood i.e. depressed mood.[…]